US equities |
NVDA $239.72 ▲+2.47% SPCX $169.24 ▲+6.47% MU $1,062.67 ▼-1.14% TSLA $379.81 ▲+2.49% SNDK $1,702.57 ▼-1.01% MSFT $528.08 ▲+2.04% INTC $116.04 ▼-2.76% META $742.92 ▲+2.04%
FinancialContent

Articles published by Good Therapeutics

News headline image
Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 Program by Roche
From Good Therapeutics
Via Business Wire
Tickers RHHBY